All stock lists
Uscb Financial Holdings, Inc. (NASDAQ:USCB)
US · Delayed Price · Currency is USD
Financial Services · Banks - Regional
19.88+0.03 (+0.15%)
Market cap
$367M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 22, 2021
Website
Insider Score
83/ 100
USCB Insider Score
Bullish1 qualifying trade · 1 insider · $20.00K bought in the last 90 days
USCB analyst forecast
USCB analyst consensus
Moderate Buy3 ratings
Buy 3 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
USCB 12-month price target
No published price targets in the last 12 months.
USCB ratings mix, last 12 months
Buy Hold Sell
Best analysts covering USCB
- Raymond James100%success rate · +23.5% avg return · 6 calls
- Keefe, Bruyette & Woods100%success rate · +25.1% avg return · 5 calls
- Piper Sandler100%success rate · +25.7% avg return · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
USCB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-10-27 |
| — | Raymond James | Outperform | — | — | Downgraded | 2026-10-26 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-08-03 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-07-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2026-04-28 |
| — | Raymond James | Strong Buy | — | — | Upgraded | 2025-09-08 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-09-08 |
| — | Raymond James | Outperform | — | — | Upgraded | 2025-07-28 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-04-28 |
| — | Raymond James | Market Perform | — | — | Downgraded | 2025-04-02 |
| — | Piper Sandler | Overweight | — | — | Upgraded | 2024-11-04 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2024-07-29 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2024-01-30 |
| — | Raymond James | Outperform | — | — | Reiterated | 2024-01-29 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2023-07-31 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2023-05-02 |
| — | Raymond James | Outperform | — | — | Reiterated | 2023-04-06 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2023-01-31 |
| — | Raymond James | Outperform | — | — | Reiterated | 2023-01-30 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2022-01-14 |
| — | Raymond James | Outperform | — | — | Reiterated | 2021-11-01 |
| — | Raymond James | Outperform | — | — | Reiterated | 2021-08-17 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2021-08-17 |
USCB earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-22 | 0.51 | 0.44 | $26.3M | $25.5M |
| 2026-04-23 | 0.48 | 0.47 | $26.0M | $26.2M |
| 2026-07-23 | 0.49 | 0.49 | $26.7M | $27.9M |
| 2026-10-22 | 0.56 | 0.51 | $29.2M | $27.0M |
| 2027-01-28Upcoming | 0.51 | — | $28.3M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.